The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

SINCE the last review of alcoholic fatty liver in this journal ... and the departments of Medicine and Pathology, Mount Sinai School of Medicine, City University of New York (address reprint ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new study says. A blood test looking for five specific proteins can predict ...

"Right now, when I see patients with early-stage fatty liver disease ... The American Journal of Pathology (2024). DOI: ...

Nonalcoholic fatty liver disease (NAFLD ... in reducing the NAFLD-induced inflammation and improving cellular histology. Successful treatment will need to include genetic or molecular-level ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...